An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it.Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see the guide to deletion. Find sources: "Oxford BioLabs" – news · newspapers · books · scholar · JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2FOxford+BioLabs%5D%5DAFD |
The topic of this article may not meet Misplaced Pages's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Oxford BioLabs" – news · newspapers · books · scholar · JSTOR (June 2011) (Learn how and when to remove this message) |
Company type | Research Organization |
---|---|
Industry | Aesthetics |
Founded | 2009 |
Founder | |
Headquarters | Oxford, England |
Website | OxbioLabs.com |
Oxford BioLabs is a UK based company focusing on the research and development of novel health & beauty therapies. It has received media attention for its hair growth product TRX2.
History & Structure
Oxford BioLabs was founded in August 2008 as a Limited Liability Company in England and Wales by former scientists of the University of Oxford, including biochemist and entrepreneur Thomas Whitfield. The company have German based Research Facilities located in Biopark Regensburg, Regensburg, Germany. According to an article published by The Daily Telegraph the company is bootstrapped by its founders as well as by NESTA and the National Council for Graduate Entrepreneurship (NCGE).
The company manufactures and distributes a dietary supplement called TRX2 (from Greek trichos for hair and 2 for second generation) which it claimed reduced hair loss - see below for controversy. The product works by engaging potassium channels, which allows them to reabsorb essential nutrients. The product is a dietary supplement, not exactly a drug, and hence it doesn't need to be approved by the U.S. Food and Drug Administration (FDA).
Controversy
In January 2014 the UK Advertising Standards Authority upheld a complaint against TRX2 and Oxford Biolabs, citing that advertisements that the company had run for TRX2 were misleading and in breach of EU advertising codes. The company agreed and changed their advertising in line with the code of conduct.
See also
References
- ^ Tyler, Richard (9 January 2011). "Thomas Whitfield's German roots help hair loss product launch". The Daily Telegraph. Retrieved 23 July 2012.
- Tyler, Richard (16 January 2009). "Thomas Whitfield: The Oxford student who plans to make baldness a thing of the past". The Daily Telegraph. Retrieved 23 July 2012.
- "Thomas Whitfield's German roots help hair loss product launch" (Web). NCEE. NCEE. 10 January 2011. Retrieved 1 August 2012.
- "TRX2 Product Information". Oxford BioLabs. Retrieved 28 November 2017.
- "Hair Loss & Alopecia" (Web). getthegloss.com. Retrieved 28 November 2017.
- Edwards, Jim (12 January 2011). "Pharma's 4 Best Shots at a Cure for Baldness" (Web). CBSNews.com. CBS News. Retrieved 1 August 2012.
it's actually just another dietary supplement and as such is not approved by the FDA.
- "Minoxidil Alternatives" (Web). MPB Research. Retrieved 1 August 2012.
- "ASA Food: Health Claims - Refer To The Relevant Nutrient" (Web). Advertising Standards Authority. Retrieved 28 November 2017.
- "ASA Adjudication on Oxford Biolabs Ltd". Advertising Standards Authority. Archived from the original on 8 October 2014. Retrieved 28 November 2017.
{{cite web}}
: CS1 maint: bot: original URL status unknown (link)
External links
- Official Website
- Website on the product TRX2
- Baldness Cure in Sight cherwell.org
- Oxford Student Working To Combat Baldness
- Oxford University press release